Harold Smith
Concepts (412)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Cytidine Deaminase | 38 | 1993 | 15 |
Why?
| RNA Editing | 37 | 1992 | 10 |
Why?
| Apolipoproteins B | 43 | 1990 | 18 |
Why?
| RNA, Messenger | 35 | 1990 | 394 |
Why?
| Cell Nucleus | 24 | 1980 | 169 |
Why?
| RNA-Binding Proteins | 9 | 1993 | 55 |
Why?
| Heterogeneous-Nuclear Ribonucleoproteins | 5 | 1992 | 8 |
Why?
| DNA, Single-Stranded | 5 | 1992 | 32 |
Why?
| vif Gene Products, Human Immunodeficiency Virus | 4 | 2007 | 2 |
Why?
| Cytidine | 6 | 1991 | 7 |
Why?
| Cytoplasm | 6 | 1986 | 108 |
Why?
| RNA | 8 | 1996 | 126 |
Why?
| Hepatocytes | 5 | 2001 | 42 |
Why?
| Liver | 19 | 1980 | 248 |
Why?
| Uridine | 5 | 1998 | 23 |
Why?
| HIV-1 | 4 | 2007 | 93 |
Why?
| Rats | 40 | 1980 | 530 |
Why?
| Alternative Splicing | 3 | 2002 | 51 |
Why?
| Base Sequence | 27 | 1990 | 371 |
Why?
| Molecular Sequence Data | 27 | 1990 | 404 |
Why?
| RNA Processing, Post-Transcriptional | 8 | 1991 | 33 |
Why?
| Ribonucleoproteins | 9 | 1986 | 21 |
Why?
| HIV Infections | 3 | 2005 | 136 |
Why?
| Animals | 54 | 1980 | 1031 |
Why?
| RNA Splicing | 7 | 1988 | 42 |
Why?
| Cell Line | 16 | 1986 | 375 |
Why?
| Biochemistry | 2 | 2002 | 15 |
Why?
| Humans | 56 | 1985 | 1856 |
Why?
| Tumor Cells, Cultured | 14 | 1996 | 233 |
Why?
| Proteins | 4 | 1988 | 192 |
Why?
| Intestine, Small | 3 | 1990 | 55 |
Why?
| Obesity | 2 | 1996 | 149 |
Why?
| Cross-Linking Reagents | 5 | 1988 | 38 |
Why?
| Models, Molecular | 4 | 2004 | 102 |
Why?
| Protein Multimerization | 1 | 2010 | 17 |
Why?
| Amino Acid Sequence | 11 | 1991 | 319 |
Why?
| Nucleoside Deaminases | 2 | 2005 | 10 |
Why?
| Ethanol | 2 | 1998 | 58 |
Why?
| Protein Structure, Tertiary | 6 | 2001 | 163 |
Why?
| Ventricular Premature Complexes | 2 | 1998 | 11 |
Why?
| HIV Core Protein p24 | 1 | 2008 | 17 |
Why?
| DNA Primers | 9 | 1994 | 208 |
Why?
| Protein Sorting Signals | 1 | 2007 | 19 |
Why?
| Recombinant Proteins | 7 | 1996 | 290 |
Why?
| Dimerization | 4 | 2006 | 92 |
Why?
| Repressor Proteins | 2 | 2005 | 96 |
Why?
| Molecular Weight | 10 | 1986 | 154 |
Why?
| Cell Hypoxia | 3 | 1991 | 31 |
Why?
| Escherichia coli | 4 | 1996 | 143 |
Why?
| Rats, Sprague-Dawley | 8 | 1993 | 257 |
Why?
| Cells, Cultured | 8 | 1989 | 447 |
Why?
| Cell Compartmentation | 3 | 1983 | 37 |
Why?
| Sequence Alignment | 5 | 1996 | 114 |
Why?
| Cell Differentiation | 2 | 1991 | 262 |
Why?
| DNA | 7 | 1984 | 262 |
Why?
| Protein Transport | 3 | 2006 | 101 |
Why?
| Ventricular Function, Left | 3 | 1992 | 41 |
Why?
| Physician Executives | 1 | 2002 | 10 |
Why?
| Genetic Variation | 1 | 2003 | 91 |
Why?
| Problem-Based Learning | 1 | 2002 | 36 |
Why?
| Perception | 1 | 2002 | 49 |
Why?
| Cardiomyopathy, Dilated | 2 | 1992 | 24 |
Why?
| HSP70 Heat-Shock Proteins | 2 | 1991 | 27 |
Why?
| Male | 27 | 1980 | 1553 |
Why?
| Gene Products, tat | 1 | 2002 | 13 |
Why?
| Nuclear Localization Signals | 1 | 2001 | 16 |
Why?
| HeLa Cells | 8 | 1985 | 107 |
Why?
| Protein Isoforms | 1 | 2002 | 86 |
Why?
| Education, Medical, Undergraduate | 1 | 2002 | 61 |
Why?
| Yeasts | 1 | 2001 | 24 |
Why?
| Genetic Techniques | 2 | 1998 | 27 |
Why?
| Active Transport, Cell Nucleus | 1 | 2001 | 55 |
Why?
| Subcellular Fractions | 3 | 1992 | 67 |
Why?
| Recombinant Fusion Proteins | 5 | 1999 | 189 |
Why?
| Sequence Homology, Amino Acid | 4 | 2002 | 156 |
Why?
| RNA Precursors | 3 | 1988 | 21 |
Why?
| Protein Binding | 3 | 1991 | 256 |
Why?
| Mutagenesis, Site-Directed | 4 | 1994 | 126 |
Why?
| Saccharomyces cerevisiae | 2 | 2000 | 67 |
Why?
| Nuclear Proteins | 4 | 1987 | 139 |
Why?
| Phosphoproteins | 3 | 1989 | 86 |
Why?
| DNA Replication | 6 | 1980 | 75 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 1998 | 13 |
Why?
| Blotting, Western | 4 | 1989 | 275 |
Why?
| Liver Neoplasms, Experimental | 4 | 1996 | 21 |
Why?
| Gene Expression | 6 | 1992 | 291 |
Why?
| Alleles | 1 | 1998 | 108 |
Why?
| Introns | 4 | 1992 | 58 |
Why?
| Protein Kinases | 2 | 1989 | 64 |
Why?
| Polymerase Chain Reaction | 6 | 1990 | 279 |
Why?
| Virus Replication | 2 | 2007 | 90 |
Why?
| Phosphorylation | 3 | 1993 | 224 |
Why?
| Kinetics | 8 | 1980 | 349 |
Why?
| Ultraviolet Rays | 3 | 1996 | 76 |
Why?
| Coronary Disease | 4 | 1988 | 94 |
Why?
| DNA, Viral | 2 | 1985 | 98 |
Why?
| Imidoesters | 3 | 1988 | 2 |
Why?
| Myelitis | 1 | 1994 | 3 |
Why?
| Cloning, Molecular | 4 | 1987 | 183 |
Why?
| Oligodeoxyribonucleotides | 5 | 1990 | 86 |
Why?
| Heart Diseases | 1 | 1996 | 92 |
Why?
| Ribonucleoproteins, Small Nuclear | 6 | 1986 | 9 |
Why?
| DNA Polymerase II | 3 | 1980 | 8 |
Why?
| Herpes Simplex | 1 | 1994 | 31 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 243 |
Why?
| Zinc | 1 | 1993 | 37 |
Why?
| Echocardiography, Doppler | 2 | 1989 | 20 |
Why?
| Spinal Cord | 1 | 1994 | 94 |
Why?
| Heart Ventricles | 3 | 1989 | 86 |
Why?
| Retinoblastoma Protein | 1 | 1993 | 26 |
Why?
| Dose-Response Relationship, Drug | 2 | 1998 | 431 |
Why?
| Liver Regeneration | 2 | 1980 | 8 |
Why?
| Cyclins | 1 | 1993 | 28 |
Why?
| Ribonucleases | 3 | 1985 | 42 |
Why?
| Genes, env | 2 | 2001 | 8 |
Why?
| Carrier Proteins | 1 | 1996 | 177 |
Why?
| Angioplasty, Balloon | 3 | 1988 | 35 |
Why?
| Glycerol | 1 | 2011 | 24 |
Why?
| Protein Interaction Mapping | 1 | 2011 | 19 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 45 |
Why?
| DNA-Directed DNA Polymerase | 2 | 1980 | 18 |
Why?
| Genetic Complementation Test | 2 | 2001 | 38 |
Why?
| Crystallization | 1 | 2011 | 34 |
Why?
| Cell Cycle | 3 | 1991 | 121 |
Why?
| Host-Pathogen Interactions | 1 | 2011 | 15 |
Why?
| Substrate Specificity | 1 | 2011 | 90 |
Why?
| Disease Models, Animal | 2 | 1996 | 349 |
Why?
| Temperature | 1 | 2011 | 137 |
Why?
| Mutagenesis | 2 | 1992 | 74 |
Why?
| Aortic Valve Stenosis | 1 | 1990 | 19 |
Why?
| Binding Sites | 3 | 1991 | 213 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2011 | 61 |
Why?
| Neurofibromin 1 | 2 | 1996 | 3 |
Why?
| Electrophoresis, Polyacrylamide Gel | 3 | 1990 | 167 |
Why?
| Trypsin | 1 | 2010 | 63 |
Why?
| Caco-2 Cells | 1 | 2009 | 4 |
Why?
| Enterocytes | 1 | 2009 | 5 |
Why?
| Apolipoprotein B-48 | 1 | 2009 | 3 |
Why?
| Membrane Proteins | 2 | 1991 | 233 |
Why?
| Mammals | 2 | 1996 | 47 |
Why?
| Biopolymers | 1 | 2009 | 12 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 1998 | 88 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 118 |
Why?
| RNA Interference | 1 | 2010 | 75 |
Why?
| Autoantigens | 1 | 1989 | 29 |
Why?
| Hypoglycemic Agents | 1 | 2010 | 44 |
Why?
| RNA Helicases | 1 | 1989 | 8 |
Why?
| Antibodies, Monoclonal | 3 | 1986 | 241 |
Why?
| Cell Fractionation | 2 | 1996 | 42 |
Why?
| Rabbits | 2 | 1998 | 252 |
Why?
| Mice | 4 | 1991 | 623 |
Why?
| Glucose | 1 | 1991 | 120 |
Why?
| Gene Expression Regulation | 2 | 1996 | 277 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 18 |
Why?
| Transfection | 3 | 1996 | 237 |
Why?
| Phenotype | 1 | 1991 | 303 |
Why?
| Angina Pectoris | 1 | 1988 | 31 |
Why?
| Fluorescent Antibody Technique | 3 | 1986 | 164 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 5 |
Why?
| Electrocardiography, Ambulatory | 2 | 1998 | 23 |
Why?
| Echocardiography | 2 | 1998 | 93 |
Why?
| Insulin | 2 | 1992 | 129 |
Why?
| DNA, Ribosomal | 1 | 1987 | 10 |
Why?
| Time Factors | 4 | 1988 | 896 |
Why?
| Retroelements | 1 | 2007 | 11 |
Why?
| Amino Acid Motifs | 1 | 2007 | 52 |
Why?
| Anti-HIV Agents | 1 | 2009 | 44 |
Why?
| Rats, Inbred Strains | 6 | 1982 | 170 |
Why?
| Virulence | 1 | 2007 | 48 |
Why?
| Ammonium Sulfate | 1 | 2007 | 7 |
Why?
| Macromolecular Substances | 2 | 1991 | 92 |
Why?
| Immunoblotting | 3 | 1988 | 119 |
Why?
| Nanostructures | 1 | 2006 | 8 |
Why?
| Carcinoma, Hepatocellular | 2 | 1996 | 53 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 3 | 1988 | 42 |
Why?
| Scattering, Radiation | 1 | 2006 | 36 |
Why?
| Leucine | 1 | 2006 | 53 |
Why?
| Phosphoprotein Phosphatases | 1 | 2006 | 21 |
Why?
| Chromatin | 5 | 1983 | 29 |
Why?
| Myocardial Infarction | 2 | 1988 | 129 |
Why?
| 2-Acetylaminofluorene | 1 | 1985 | 1 |
Why?
| Phylogeny | 1 | 2006 | 63 |
Why?
| Chromosomes | 1 | 1986 | 32 |
Why?
| Immunohistochemistry | 3 | 1994 | 355 |
Why?
| Viremia | 1 | 2005 | 18 |
Why?
| Mitosis | 1 | 1986 | 68 |
Why?
| Autoradiography | 3 | 1984 | 73 |
Why?
| Adenoviruses, Human | 1 | 1985 | 10 |
Why?
| CD4 Lymphocyte Count | 1 | 2005 | 50 |
Why?
| Models, Biological | 1 | 2011 | 410 |
Why?
| Leukocytes, Mononuclear | 1 | 2005 | 67 |
Why?
| Mice, Inbred C57BL | 1 | 2010 | 318 |
Why?
| Deamination | 1 | 2004 | 3 |
Why?
| Enzyme Activation | 1 | 2006 | 177 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2004 | 8 |
Why?
| Models, Genetic | 2 | 1991 | 90 |
Why?
| Stroke Volume | 2 | 1990 | 54 |
Why?
| Protein Folding | 1 | 2004 | 30 |
Why?
| DNA, Complementary | 2 | 1999 | 139 |
Why?
| Aged | 8 | 1988 | 988 |
Why?
| Enzyme Inhibitors | 1 | 2006 | 216 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2006 | 113 |
Why?
| Disease Progression | 1 | 2005 | 244 |
Why?
| Quality Control | 1 | 2003 | 54 |
Why?
| Biological Markers | 1 | 2005 | 262 |
Why?
| Cell Culture Techniques | 1 | 2003 | 74 |
Why?
| Transcription, Genetic | 3 | 1986 | 253 |
Why?
| Apolipoprotein B-100 | 1 | 2002 | 5 |
Why?
| Cricetinae | 2 | 1987 | 130 |
Why?
| Emetine | 1 | 2001 | 6 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 11 |
Why?
| Cytosine | 1 | 2002 | 20 |
Why?
| Dactinomycin | 1 | 2001 | 40 |
Why?
| Protein Synthesis Inhibitors | 1 | 2001 | 33 |
Why?
| Life Change Events | 1 | 2002 | 50 |
Why?
| Spliceosomes | 1 | 2001 | 7 |
Why?
| Microscopy, Electron | 3 | 1984 | 178 |
Why?
| Fatty Acids, Unsaturated | 1 | 2001 | 22 |
Why?
| Exons | 1 | 2002 | 91 |
Why?
| Markov Chains | 1 | 2001 | 25 |
Why?
| Antibiotics, Antineoplastic | 1 | 2001 | 35 |
Why?
| Lipoproteins | 1 | 2002 | 52 |
Why?
| Plasmids | 2 | 1991 | 122 |
Why?
| Open Reading Frames | 1 | 2001 | 56 |
Why?
| Antigens, Nuclear | 2 | 1989 | 10 |
Why?
| Follow-Up Studies | 6 | 1988 | 553 |
Why?
| Genes, Reporter | 1 | 2001 | 111 |
Why?
| RNA, Fungal | 1 | 2001 | 26 |
Why?
| Risk Factors | 2 | 1990 | 555 |
Why?
| Syndrome | 2 | 1994 | 142 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 58 |
Why?
| Middle Aged | 7 | 1988 | 1161 |
Why?
| Methyltransferases | 1 | 1999 | 18 |
Why?
| Heart Rate | 2 | 1992 | 138 |
Why?
| Female | 8 | 1988 | 1643 |
Why?
| Attitude of Health Personnel | 1 | 2002 | 165 |
Why?
| DNA Polymerase I | 3 | 1980 | 7 |
Why?
| Tissue Distribution | 1 | 1999 | 124 |
Why?
| Enhancer Elements, Genetic | 1 | 1999 | 43 |
Why?
| Luminescent Proteins | 1 | 1999 | 67 |
Why?
| Catheter Ablation | 1 | 2000 | 38 |
Why?
| Promoter Regions, Genetic | 1 | 2002 | 188 |
Why?
| Amiodarone | 1 | 1998 | 10 |
Why?
| Green Fluorescent Proteins | 1 | 1999 | 105 |
Why?
| Electrophoresis, Agar Gel | 1 | 1998 | 27 |
Why?
| Genes, Wilms Tumor | 1 | 1998 | 4 |
Why?
| Hockey | 1 | 1998 | 2 |
Why?
| Indicators and Reagents | 1 | 1998 | 79 |
Why?
| DNA Ligases | 1 | 1998 | 7 |
Why?
| RNA, Guide | 1 | 1997 | 4 |
Why?
| RNA, Protozoan | 1 | 1997 | 6 |
Why?
| Adenosine Deaminase | 1 | 1997 | 8 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 34 |
Why?
| Receptors, Glutamate | 1 | 1997 | 13 |
Why?
| Stearic Acids | 1 | 1997 | 7 |
Why?
| Oleic Acid | 1 | 1997 | 14 |
Why?
| Evaluation Studies as Topic | 1 | 1998 | 178 |
Why?
| Chromatography, Affinity | 1 | 1997 | 49 |
Why?
| Anti-Arrhythmia Agents | 1 | 1998 | 36 |
Why?
| Adrenergic beta-Antagonists | 1 | 1998 | 47 |
Why?
| Catalysis | 1 | 1997 | 40 |
Why?
| Species Specificity | 1 | 1998 | 186 |
Why?
| CHO Cells | 1 | 1997 | 65 |
Why?
| COS Cells | 1 | 1997 | 73 |
Why?
| DCMP Deaminase | 1 | 1996 | 2 |
Why?
| Intestines | 2 | 1993 | 83 |
Why?
| Glucuronidase | 1 | 1996 | 26 |
Why?
| Consensus Sequence | 1 | 1996 | 39 |
Why?
| Rats, Zucker | 1 | 1996 | 7 |
Why?
| Liver Neoplasms | 1 | 1998 | 97 |
Why?
| Point Mutation | 1 | 1998 | 122 |
Why?
| Hyperinsulinism | 1 | 1996 | 10 |
Why?
| Hypertriglyceridemia | 1 | 1996 | 14 |
Why?
| Polymorphism, Genetic | 1 | 1998 | 94 |
Why?
| Psychomotor Performance | 1 | 1998 | 69 |
Why?
| Heart Valve Diseases | 1 | 1996 | 18 |
Why?
| Nucleic Acid Hybridization | 2 | 1985 | 94 |
Why?
| Cell-Free System | 1 | 1996 | 34 |
Why?
| Methionine | 1 | 1996 | 38 |
Why?
| RNA, Neoplasm | 1 | 1996 | 41 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 43 |
Why?
| Insulin Resistance | 1 | 1996 | 37 |
Why?
| RNA, Viral | 1 | 1997 | 91 |
Why?
| Heart Valves | 1 | 1995 | 7 |
Why?
| Carcinoid Heart Disease | 1 | 1995 | 4 |
Why?
| Cytosol | 1 | 1996 | 79 |
Why?
| Heart Valve Prosthesis | 1 | 1995 | 23 |
Why?
| Herpesvirus 2, Human | 1 | 1994 | 7 |
Why?
| Necrosis | 1 | 1994 | 82 |
Why?
| Atrial Fibrillation | 2 | 1992 | 40 |
Why?
| Heart Failure | 2 | 1992 | 106 |
Why?
| Sensitivity and Specificity | 1 | 1998 | 427 |
Why?
| Fatal Outcome | 1 | 1994 | 86 |
Why?
| Salts | 1 | 1993 | 7 |
Why?
| Phenanthrolines | 1 | 1993 | 7 |
Why?
| Atrial Natriuretic Factor | 1 | 1994 | 15 |
Why?
| Terminology as Topic | 1 | 1995 | 81 |
Why?
| Chimera | 1 | 1994 | 22 |
Why?
| Iron Chelating Agents | 1 | 1993 | 5 |
Why?
| Adult | 5 | 1988 | 1317 |
Why?
| Tachycardia | 1 | 1994 | 32 |
Why?
| Cardiomyopathies | 1 | 1994 | 43 |
Why?
| Antigens, Viral | 1 | 1994 | 53 |
Why?
| Arrhythmias, Cardiac | 1 | 1996 | 65 |
Why?
| Structure-Activity Relationship | 1 | 1994 | 124 |
Why?
| Brain Diseases | 1 | 1994 | 75 |
Why?
| Nucleic Acid Conformation | 2 | 1985 | 56 |
Why?
| Haplorhini | 1 | 1993 | 43 |
Why?
| S Phase | 1 | 1993 | 29 |
Why?
| Heart Rupture, Post-Infarction | 1 | 1992 | 2 |
Why?
| Organ Specificity | 1 | 1993 | 104 |
Why?
| Prognosis | 3 | 1989 | 388 |
Why?
| Treatment Outcome | 2 | 1995 | 661 |
Why?
| Peptide Chain Elongation, Translational | 1 | 1992 | 7 |
Why?
| Acute Disease | 1 | 1994 | 271 |
Why?
| Nuclear Matrix | 1 | 1992 | 2 |
Why?
| RNA, Heterogeneous Nuclear | 1 | 1992 | 3 |
Why?
| Dietary Carbohydrates | 1 | 1992 | 23 |
Why?
| RNA Caps | 1 | 1992 | 5 |
Why?
| Apolipoproteins E | 1 | 1992 | 26 |
Why?
| Coronary Angiography | 2 | 1988 | 49 |
Why?
| Organelles | 1 | 1992 | 17 |
Why?
| Fasting | 1 | 1992 | 41 |
Why?
| Diabetes Mellitus, Experimental | 1 | 1992 | 36 |
Why?
| Aortic Aneurysm | 1 | 1991 | 16 |
Why?
| Retrospective Studies | 1 | 1998 | 653 |
Why?
| DNA Mutational Analysis | 1 | 1991 | 110 |
Why?
| Oligonucleotide Probes | 1 | 1991 | 40 |
Why?
| Ribonuclease T1 | 1 | 1990 | 2 |
Why?
| Ribonuclease, Pancreatic | 1 | 1990 | 7 |
Why?
| Staining and Labeling | 1 | 1991 | 101 |
Why?
| Sulfhydryl Compounds | 1 | 1990 | 42 |
Why?
| Muscles | 1 | 1991 | 111 |
Why?
| Muscle Proteins | 1 | 1991 | 56 |
Why?
| Heart Catheterization | 1 | 1990 | 47 |
Why?
| Coronary Circulation | 1 | 1990 | 41 |
Why?
| Blood Flow Velocity | 1 | 1990 | 72 |
Why?
| Aging | 1 | 1996 | 275 |
Why?
| Cell Survival | 1 | 1991 | 229 |
Why?
| DEAD-box RNA Helicases | 1 | 1989 | 12 |
Why?
| Radioimmunoassay | 1 | 1989 | 81 |
Why?
| Cross Reactions | 1 | 1989 | 63 |
Why?
| Mutation | 2 | 2004 | 340 |
Why?
| Myocardial Contraction | 1 | 1989 | 52 |
Why?
| Clinical Enzyme Tests | 1 | 1988 | 15 |
Why?
| Cell Division | 1 | 1991 | 273 |
Why?
| Oxygen | 1 | 1991 | 179 |
Why?
| Angiocardiography | 1 | 1988 | 7 |
Why?
| Antibodies | 1 | 1989 | 159 |
Why?
| Myocardial Reperfusion Injury | 1 | 1989 | 29 |
Why?
| Hybrid Cells | 1 | 1987 | 16 |
Why?
| Metals | 1 | 1988 | 35 |
Why?
| Centrifugation, Density Gradient | 2 | 1982 | 48 |
Why?
| Takifugu | 1 | 2006 | 7 |
Why?
| Nuclear Export Signals | 1 | 2006 | 7 |
Why?
| NIH 3T3 Cells | 1 | 2006 | 22 |
Why?
| Isoelectric Point | 1 | 1986 | 14 |
Why?
| Immunosorbent Techniques | 1 | 1986 | 22 |
Why?
| Telophase | 1 | 1986 | 1 |
Why?
| Anaphase | 1 | 1986 | 4 |
Why?
| Prophase | 1 | 1986 | 4 |
Why?
| Metaphase | 1 | 1986 | 11 |
Why?
| Cell Nucleolus | 1 | 1986 | 13 |
Why?
| Immunoglobulin Class Switching | 1 | 2006 | 17 |
Why?
| Interphase | 1 | 1986 | 26 |
Why?
| Catalytic Domain | 1 | 2006 | 27 |
Why?
| Edetic Acid | 1 | 1986 | 41 |
Why?
| Solubility | 1 | 1986 | 75 |
Why?
| Xenopus Proteins | 1 | 2006 | 15 |
Why?
| Recurrence | 1 | 1988 | 261 |
Why?
| Age Factors | 3 | 1989 | 480 |
Why?
| Guanosine | 1 | 1985 | 12 |
Why?
| Phosphorus Radioisotopes | 1 | 1985 | 20 |
Why?
| Prospective Studies | 1 | 1990 | 545 |
Why?
| Deoxyribonuclease I | 1 | 1985 | 16 |
Why?
| Xenopus laevis | 1 | 2006 | 49 |
Why?
| Aged, 80 and over | 2 | 1988 | 599 |
Why?
| Cell Transformation, Viral | 1 | 1985 | 35 |
Why?
| Immunoglobulin M | 1 | 2004 | 81 |
Why?
| Crystallography, X-Ray | 1 | 2004 | 41 |
Why?
| Electrocardiography | 1 | 1988 | 132 |
Why?
| Protein Conformation | 1 | 2004 | 123 |
Why?
| Biopsy | 2 | 1992 | 207 |
Why?
| Cardiac Output | 2 | 1989 | 48 |
Why?
| Betaine-Homocysteine S-Methyltransferase | 1 | 1999 | 4 |
Why?
| Reference Values | 1 | 1980 | 278 |
Why?
| Linear Models | 1 | 1998 | 151 |
Why?
| Bioprosthesis | 1 | 1995 | 9 |
Why?
| Actuarial Analysis | 1 | 1995 | 21 |
Why?
| Heart Septum | 1 | 1992 | 14 |
Why?
| Survival Analysis | 1 | 1995 | 205 |
Why?
| Streptozocin | 1 | 1992 | 18 |
Why?
| Serum Albumin | 1 | 1992 | 55 |
Why?
| Chronic Disease | 1 | 1994 | 267 |
Why?
| Mitral Valve Insufficiency | 1 | 1991 | 19 |
Why?
| Aortic Valve Insufficiency | 1 | 1991 | 15 |
Why?
| Ribosomes | 1 | 1992 | 26 |
Why?
| Hemodynamics | 1 | 1992 | 131 |
Why?
| Aorta, Thoracic | 1 | 1991 | 54 |
Why?
| Regression Analysis | 1 | 1992 | 256 |
Why?
| Sex Factors | 1 | 1992 | 284 |
Why?
| Diagnosis, Differential | 1 | 1992 | 402 |
Why?
| Child | 1 | 1998 | 749 |
Why?
| Coronary Artery Bypass | 1 | 1989 | 46 |
Why?
| Fibrinolytic Agents | 1 | 1989 | 42 |
Why?
| Calibration | 1 | 1988 | 37 |
Why?
| Adolescent | 1 | 1998 | 891 |
Why?
| Length of Stay | 1 | 1989 | 166 |
Why?
| Deoxycytosine Nucleotides | 1 | 1985 | 5 |
Why?
| Thymine Nucleotides | 1 | 1985 | 8 |
Why?
| Bromodeoxyuridine | 1 | 1985 | 47 |
Why?
| Magnetic Resonance Imaging | 1 | 1991 | 294 |
Why?
|
|
Smith's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
